REG - Tristel PLC - Result of AGM

TristelAnnouncement

16/12/2024 15:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20241216:nRSP2739Qa&default-theme=true

RNS Number : 2739Q  Tristel PLC  16 December 2024

TRISTEL plc

("Tristel" or the "Company")

 

Result of AGM

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that at the Annual General Meeting held earlier today, all
resolutions were duly passed.

 

The results of the AGM will be made available on the Company's website:
https://investors.tristel.com/investor-hub/
(https://investors.tristel.com/investor-hub/)

 

The Company confirms that in relation to Resolution 6, the performance
targets for the initial long-term incentive plan (LTIP) awards will be 50%
based on earning per share (EPS) targets and 50% based on relative total
shareholder return (TSR) versus the constituents of the AIM 100 as at the
grant of the awards as follows:

 

 50% of Initial awards                          50% of Initial awards
 EPS FY 26/27         % of EPS Part that Vests  Relative TSR measured over 3 years from grant  % of TSR Part that Vests
 Less than 18p        0%                        Below median                                   0%
 Between 18p and 25p  Pro-rata 25% to 100%      Between median and upper quartile              Pro-rata 25% to 100%
 25p or better        100%                      Upper quartile or above                        100%

 

 

 

For further information please contact:

 

 Tristel plc                                                                  Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                        www.investors.tristel.com (http://www.investors.tristel.com/)
 Liz Dixon, Chief Financial Officer

 Walbrook PR Ltd                                                              Tel: 020 7933 8780 or tristel@walbrookpr.com
 Paul McManus / Lianne Applegarth / Alice Woodings    Mob: 07980 541 893/ 07584 391 303/ 07407 804 654

 Cavendish Capital Markets Ltd                                                Tel: 020 7220 0500
 Geoff Nash / Camilla Hume / Trisyia Jamaludin (Corporate Finance)
 Sunila de Silva (ECM) / Louise Talbot (Sales)

 

About Tristel plc

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, a more sustainable alternative to commonly used
pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 270 people across 16
subsidiaries selling into 40+ countries. The Company targets annual revenue
growth of between 10% and 15% and an EBITDA margin of at least 25% and the
business is profitable, with no debt and has a progressive dividend policy.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  RAGFLFSSFSLRLIS